AURORA, Colo., Jan. 27, 2026 /PRNewswire/ — Navidence, a technology company focused on defining health data and supporting researchers in study design, today announced it has completed its Series Seed preferred funding round, co-led by Grand Ventures (Grand Rapids, Michigan) and Nina…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
— Novel coils from Embolization, Inc., demonstrate consistent performance across a range of cases — BOULDER, Colo., Aug. 20, 2026 /PRNewswire/ — The novel, radiopaque, polymer-based embolic coil from Embolization, Inc., has now topped 125 […]
An even 300 staff members at the University of Colorado Anschutz Medical Campus were honored at the recent Staff Years of Service Recognition Event. Chancellor Don Elliman attended the reception, which is an annual event […]
Imagine how lonely it must feel to be sick – the kind of sick that doesn’t get better with rest or time – and not having a definitive diagnosis. Despite multiple specialists and extensive tests, […]
Copyright © 2026 Biotech Networks
